Effect of ketoconazole plus low-dose prednisone on progression of chronic renal failure

American Journal of Kidney Diseases

Volumn 29, Issue 4, 1997, Pages 503-513

  Walser, Mackenzie ^a   Hill, Sylvia ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

corticotropin; cortisol; Diabetic nephropathy; glomerulonephritis; interstitial nephritis; nitrate excretion; polycystic kidney disease; proteinuria

Indexed keywords

HYDROCORTISONE; KETOCONAZOLE; PREDNISONE;

ADULT; AGED; ARTICLE; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DIABETIC NEPHROPATHY; DRUG EFFICACY; DRUG SAFETY; FATIGUE; FEMALE; GLOMERULOPATHY; GLOMERULUS FILTRATION RATE; HUMAN; INTERSTITIAL NEPHRITIS; KIDNEY POLYCYSTIC DISEASE; LIVER TOXICITY; MALE; NAUSEA; RANDOMIZED CONTROLLED TRIAL; VOMITING;

EID: 0030898151     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-6386(97)90331-0     Document Type: Article

References (46)

1. Walser M, Ward L: Progression of chronic renal failure is related to glucocorticoid production. Kidney Int 34:859-866, 1988
2. Walser M: Progression of chronic renal failure in man. Kidney Int 37:1195-1210, 1990
3. Walser M: Weighted least squares regression analysis of factors contributing to progression of chronic renal failure. Contrib Nephrol 75:127-133, 1989
4. Baxter JD, Tyrrell JB: The adrenal cortex, in Felig P, Baxter JD, Broadus E, Frohman LA (eds): Endocrinology and Metabolism (ed 2). New York, NY, McGraw Hill, 1987, pp 511-650
5. Krieger DT: Rhythms in CRF, ACTH and corticosteroids, in Krieger DT (ed): Endocrine Rhythms. New York, NY, Raven, 1979, pp 123-142
6. Wetzels JFM, Gerlag PGG, Sluiter HE, Hoitsma ASJ, Koene RAP: Prednisone-induced fluctuations of proteinuria in patients with a nephrotic syndrome. Nephron 44:344-350, 1986
7. Maeda T, Furukawa I, Suzuki T, Mori T: Reduction of proteinuria by adrenalectomy and its restoration by glucocorticoids in rats bearing functioning pituitary tumor. Nephron 55:181-186, 1990
8. Pessina AC, Peart WS: Renin induced proteinuria and the effects of adrenalectomy. I. Haemodynamic changes in relation to function. Proc R Soc Lond [Biol] 180:43-60, 1972
9. Cameron JS: Proteinuria and progression in human glomerular diseases. Am J Nephrol 10:81-87, 1990 (suppl 1)
10. Rossing P, Hommel E, Smidt UM, Parving HH: Impact of arterial blood pressure and albuminuria on the progression of diabetic nephropathy in IDDM patients. Diabetes 42:715-719, 1993
11. Klahr S, Levey AS, Beck GJ, Caggiula AW, Hunsicker L, Kusek JW, Striker G, and the Modification of Diet in Renal Disease Study Group: The effects of dietary protein restriction and blood pressure control on the progression of chronic renal disease. N Engl J Med 330:877-884, 1994
12. Lelcuk S, Huval WV, Valeri CR, Shepro D, Hechtman HB: Inhibition of ischemia-induced thromboxane synthesis in man. J Trauma 24:393-396, 1984
13. Nardone PA, Slotman GJ, Vezeridis MP: Ketoconazole: A thromboxane synthetase and 5-lipoxygenase inhibitor with antimetastatic activity in B16-F10 melanoma. J Surg Res 44:425-429, 1988
14. Gordge MP, Leaker BR, Rylance PB, Neild GH: Haemostatic activation and proteinuria as factors in the progression of chronic renal failure. Nephrol Dial Transplant 6:21-26, 1991
15. Bogle RG, Whitely GS, Soo SC, Johnstone AP, Vallance P: Effect of anti-fungal imidazoles on messenger RNA levels and enzyme activity of inducible nitric oxide synthase. Br J Pharmacol 111:1257-1261, 1994
16. Walser M: Urinary nitrate and progression of chronic renal failure. J Invest Med 43:394A, 1995 (abstr) (suppl 2)
17. Walser M, Hill S, Tomalis EA: Treatment of nephrotic adults with a supplemented, very low-protein diet. Am J Kidney Dis 28:354-364, 1996
18. Walser M, Hill S, Ward L, Magder L: A crossover comparison of progression of chronic renal failure: Ketoacids vs. amino acids. Kidney Int 43:933-939, 1993
19. Walser M: Progression of renal failure, in Davison AM (ed): Proceedings of the Xth International Congress in Nephrology. East Sussex, UK, Holt-Saunders, 1988, pp 1155-1181
20. Silber RH, Porter CC: The determination of 17,21-dihydroxy-20-ketosteroids in urine and plasma. J Biol Chem 210:923-932, 1954
21. Moshage H, Kok B, Huizenga JR, Jansen PLM: Nitrite and nitrate determinations in plasma: A critical evaluation. Clin Chem 41:892-896, 1995
22. Cauwenbergh C: Safety aspects of ketoconazole, the most commonly used systemic antifungal. Mycoses 32:59-63, 1989 (suppl 2)
23. Lake-Bakaar G, Scheuer PJ, Sherlock S: Hepatic reactions associated with ketoconazole in the United Kingdom. BMJ 294:419-422, 1987
24. Terzolo M, Panarelli M, Piovesan A, Torta M, Paccotti P, Angeli A: Ketoconazole treatment in Cushing's disease. Effect on the circadian profile of plasma ACTH and cortisol. J Endocrinol Invest 11:717-721, 1988
25. Leal-Cerro A, Garcia-Luna PP, Pereira JL, Serrera JL, Pumar A, Astorga R: Ketoconazole: A new type of agent in the treatment of hypercholesterolemia? Horm Metab Res 22:398-399, 1990
26. Rollman O, Jameson S, Lithell H: Effects of long-term ketoconazole on serum lipid levels. Eur J Clin Pharmacol 29:241-245, 1985
27. Kesaniemi YA, Miettinen TA: Inhibition of cholesterol absorption by neomycin, benzodiazepine derivatives and ketoconazole. Eur J Clin Pharmacol 40:S65-S67, 1991 (suppl 1)
28. Dushkin MI, Zenkov NK, Menshikova EB, Pivovarova EN, Lyubimov GY, Volsky NN: Ketoconazole inhibits oxidative modification of low density lipoprotein. Atherosclerosis 114:9-18, 1995
29. Matsusue S, Walser M: Healing of intestinal anastomoses in adrenalectomized rats given corticosterone. Am J Physiol 263:R164-R168, 1992
30. Ryoyama K, Nomura T, Nakamura S: Inhibition of macrophage nitric oxide production by arachidonate-cascade inhibitors. Cancer Immunol Immunother 37:385-391, 1993
31. Bogle R, Vallance P: Ketoconazole and nitric oxide. Crit Care Med 23:600, 1995
32. Whitworth JA, Gordon D, McLachlan-Troup N, Scoggins B, Moulds RWF: Dexamethasone suppression in essential hypertension: Effects on Cortisol and blood pressure. Clin Exp Hypertens [A] A11:323-335, 1989
33. Modification of Diet in Renal Disease Study Group: The Modification of Diet in Renal Disease Study: Design, methods, and results from the Feasibility Study. Am J Kidney Dis 20:18-33, 1992
34. Daneshmend TK: Diseases and drugs but not food decrease ketoconazole bioavailability. Br J Clin Pharmacol 29:783-784, 1990
35. Chapman JR, Warnock DW: Ketoconazole and fungal CAPD peritonitis. Lancet 2:510-511, 1983
36. Boelaert J, Schurgers M, Matthys E, Daneel R, van Peer A, De Beule K, Woestenborghs R, Heykantsm J: Itraconazole pharmacokinetics in patients with renal dysfunction. Antimicrob Agents Chemother 32:1595-1597, 1988
37. Johnson RJ, Blair AD, Ahmad S: Ketoconazole kinetics in chronic peritoneal dialysis. Clin Pharmacol Ther 37:325-329, 1985
38. Meyer JC, Burri C, Ruf P, Schnyder UW: Factors affecting plasma levels of ketoconazole during long-term treatment. Dermatologica 178:29-32, 1989
39. Badcock NR, Bartholomeusz FD, Frewin DB, Sansom LN, Reid JG: The pharmacokinetics of ketoconazole after chronic administration in adults. Eur J Clin Pharmacol 33:531-534, 1987
40. Bradbrook ID, Gillies HC, Morrison PJ, Robinson J, Rogers HJ, Spector RG: Effects of single and multiple doses of ketoconazole on adrenal function in normal subjects. Br J Clin Pharmacol 20:163-165, 1985
41. Rotstein DM, Kertesz DJ, Walker KA, Swinney DC: Stereoisomers of ketoconazole: Preparation and biological activity. J Med Chem 35:2818-2825, 1992
42. Krishnaiah YS, Satyanarayana S, Visweswaram D: Interaction between tolbutamide and ketoconazole in healthy subjects. Br J Clin Pharmacol 37:205-207, 1994
43. Effendy I, Krause W: In vivo effects of terbinafine and ketoconazole on testosterone plasma levels in healthy males. Dermatologica 178:103-106, 1989
44. Akalin S: Effects of ketoconazole in hirsute women. Acta Endocrinol 124:19-22, 1991
45. Pont A, Goldman ES, Sugar AM, Siiteri PK, Stevens DA: Ketoconazole-induced increase in estradiol-testosterone ratio. Probable explanation for gynecomastia. Arch Intern Med 145:1429-1431, 1985
46. Glass AR, Eil C: Ketoconazole-induced reduction in serum 1,25-dihdroxyvitamin D. J Clin Endocrinol Metab 63:766-769, 1986